We highlight the clinical significance of CEACAM expression in HNSCC and provide a theoretical basis for further studies on CERCAM-targeted inhibitors for adjuvant treatment of head and neck squamous carcinoma. This evidence concerns the gene CERCAM and head and neck squamous cell carcinoma.